Table 1 Summary of clinical and pathological data of 79 tumor samples
From: Integrating chromosomal aberrations and gene expression profiles to dissect rectal tumorigenesis
| Â | A/A | A/C | AC/C | C/C | C/C(N+) |
|---|---|---|---|---|---|
Tissue fraction analyzed | Adenoma | Adenoma | Adenoma and carcinoma mixture | Carcinoma | Carcinoma |
Tumor stage | Adenoma | Carcinoma | Carcinoma | Carcinoma | Carcinoma |
Treatment | Â | Â | Â | Â | Â |
TEM | 24 | 6 | 5 | 3 | 1 |
TME | 4 | 3 | 2 | 20 | 11 |
Sex (M/F) | 15/13 | 2/7 | 3/4 | 10/13 | 10/2 |
Age (mean) | 69 | 71 | 64 | 66 | 62 |
Dysplasia (adenoma) | Â | Â | Â | Â | Â |
Low | 15 | Â | Â | Â | Â |
high | 9 | Â | Â | Â | Â |
Stage (carcinoma) | Â | Â | Â | Â | Â |
T1 | Â | 7 | 3 | 11 | Â |
T2 | Â | 2 | 3 | 12 | 12 |
T3 | Â | Â | 1 | Â | Â |
Size(cm) (mean) | 5.9 | 4.4 | 4.2 | 3.2 | 5.1 |
Genomic data | Â | Â | Â | Â | Â |
Samples typed(n) | 21 | 8 | 7 | 19 | 11 |
Abberations (%) | Â | Â | Â | Â | Â |
1q23 gain | 0 | 9 | 11 | 14 | 62 |
8q22-24 gain | 9 | 18 | 44 | 50 | 62 |
13q gain | 4 | 36 | 67 | 59 | 85 |
17p loss | 17 | 18 | 44 | 91 | 62 |
18q12-22 loss | 17 | 36 | 56 | 86 | 77 |
20q gain | 17 | 27 | 78 | 86 | 92 |